APMA continues to work closely with state components on legislative strategy, stakeholder engagement, testimony development, grassroots advocacy, and regulatory outreach across multiple states. The following update highlights recent activity affecting podiatric physicians nationwide.
Tennessee Scope of Practice
SB 2358 / HB 2021, which would add “soft tissue of the lower leg distal to the tibial tuberosity” to podiatric scope of practice, continues to gain momentum in Tennessee. The Senate passed the bill, additional sponsors joined on, and the bill has been placed on the calendar for the House Health Committee.
Massachusetts Scope of Practice
H 2407 / S 1542 remains active. In November 2025, the Committee on Health Care Financing reported S 1542 favorably and referred it to Senate Ways and Means. This allows the legislation to continue to advance.
Mississippi Scope of Practice
Despite a comprehensive advocacy effort, SB 2442 did not advance out of committee this session. The Mississippi Podiatric Medical Association (MsPMA) is already engaging legislators about reintroducing the bill next year. Separately, SB 2444, which directs the Mississippi State Department of Health to study the prevention and reduction of diabetes-related amputations, has passed the Senate.
Interstate Podiatric Medical Licensure Compact (IPMLC)
Several states are actively considering compact adoption:
Arizona: HB 2438 passed the House on February 25.
Florida: SB 1312 has been introduced and is awaiting committee consideration.
Iowa: HF 2498 passed the House.
Maryland: SB 333 / HB 619 were introduced in both chambers. Following a Senate Finance Committee hearing and stakeholder testimony, the bill has not yet received a favorable report.
Ohio: SB 354 has been introduced and referred to the Senate Health Committee, but no House companion bill has been identified yet.
Contact the APMA Advocacy Department with any questions at advocacy@apma.org.